European Journal of Pharmaceutical Sciences最新文献

筛选
英文 中文
Corrigendum to "Evaluation of transduction properties and vaccine efficacy of a simian adenovirus type 25-based vector" [European Journal of Pharmaceutical Sciences 225 (2026)107619]. “基于猴腺病毒25型载体的转导特性和疫苗效力的评估”[欧洲制药科学杂志225(2026)107619]的勘误表。
IF 5.1 3区 医学
European Journal of Pharmaceutical Sciences Pub Date : 2026-12-01 Epub Date: 2026-09-12 DOI: 10.1016/j.ejps.2026.107658
Fuka Okumura, Sora Tokuoka, Naoya Nagata, Rika Onishi, Aoi Shiota, Fuminori Sakurai, Kahori Shimizu, Hiroyuki Mizuguchi
{"title":"Corrigendum to \"Evaluation of transduction properties and vaccine efficacy of a simian adenovirus type 25-based vector\" [European Journal of Pharmaceutical Sciences 225 (2026)107619].","authors":"Fuka Okumura, Sora Tokuoka, Naoya Nagata, Rika Onishi, Aoi Shiota, Fuminori Sakurai, Kahori Shimizu, Hiroyuki Mizuguchi","doi":"10.1016/j.ejps.2026.107658","DOIUrl":"10.1016/j.ejps.2026.107658","url":null,"abstract":"","PeriodicalId":12018,"journal":{"name":"European Journal of Pharmaceutical Sciences","volume":" ","pages":"107658"},"PeriodicalIF":5.1,"publicationDate":"2026-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"148955199","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Corrigendum to "LARS inhibition overcomes regorafenib resistance in hepatocellular carcinoma via ferroptosis and drug metabolism" [European Journal of Pharmaceutical Sciences 225 (2026)107614]. “LARS抑制通过铁下垂和药物代谢克服肝细胞癌的瑞非尼耐药”的更正[欧洲药物科学杂志225(2026)107614]。
IF 5.1 3区 医学
European Journal of Pharmaceutical Sciences Pub Date : 2026-12-01 Epub Date: 2026-10-25 DOI: 10.1016/j.ejps.2026.107695
Tung-Yao Tsai, Hsuan-Hwai Lin, Yi-Chiao Cheng, Vijesh Kumar Yadav, Chun-Chen Ko, Yih-Giun Cherng, Shiue-Wei Lai
{"title":"Corrigendum to \"LARS inhibition overcomes regorafenib resistance in hepatocellular carcinoma via ferroptosis and drug metabolism\" [European Journal of Pharmaceutical Sciences 225 (2026)107614].","authors":"Tung-Yao Tsai, Hsuan-Hwai Lin, Yi-Chiao Cheng, Vijesh Kumar Yadav, Chun-Chen Ko, Yih-Giun Cherng, Shiue-Wei Lai","doi":"10.1016/j.ejps.2026.107695","DOIUrl":"10.1016/j.ejps.2026.107695","url":null,"abstract":"","PeriodicalId":12018,"journal":{"name":"European Journal of Pharmaceutical Sciences","volume":" ","pages":"107695"},"PeriodicalIF":5.1,"publicationDate":"2026-12-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149264685","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Development of a non-targeted fingerprint profiling LC-HRMS method combined with chemometric analysis as a new approach for the detection of unexpected impurities. 建立了一种结合化学计量分析的非目标指纹图谱LC-HRMS方法,作为检测意外杂质的新方法。
IF 5.1 3区 医学
European Journal of Pharmaceutical Sciences Pub Date : 2026-11-14 DOI: 10.1016/j.ejps.2026.107720
Mandy Schneider, Jürgen Meins, Viktor Sandner, Manfred Schubert-Zsilavecz, Mona Abdel-Tawab
{"title":"Development of a non-targeted fingerprint profiling LC-HRMS method combined with chemometric analysis as a new approach for the detection of unexpected impurities.","authors":"Mandy Schneider, Jürgen Meins, Viktor Sandner, Manfred Schubert-Zsilavecz, Mona Abdel-Tawab","doi":"10.1016/j.ejps.2026.107720","DOIUrl":"https://doi.org/10.1016/j.ejps.2026.107720","url":null,"abstract":"<p><p>Valsartan drugs were recalled in 2018 because of the coincidental discovery of unexpected N-nitrosodimethylamine (NDMA). The fact that NDMA was not detected by the established comprehensive quality control methods is mainly due to the targeted approach applied being devoted to the determination of known and expected impurities. This study examines the use of a non-targeted screening approach to monitor the fingerprint profiles of finished products for unexpected impurities. To this end, we developed a profiling method for ramipril tablets using LC-HRMS coupled with SIMCA (soft independent modelling of class analogies) chemometric analysis. Fingerprint profiles were generated using a pentafluorophenyl reversed phase column with a methanol/water gradient coupled to a qTOF mass spectrometer with electrospray ionization in positive and negative mode. By applying chemometric analysis to the untargeted fingerprint profiles, it was possible to distinguish the fingerprint profiles generated from \"clean\" and spiked ramipril batches at impurity concentrations as low as 10 µg/L demonstrating the methods suitability for trace-level impurity profiling. SIMCA even allowed the identification of the substances responsible for the deviations in the fingerprint profiles. This study shows that untargeted fingerprint profiling coupled with multivariate data analysis is capable of being applied in addition to existing targeted quality control methods as a proactive approach to detect unexpected impurities instead of reactive batch recalls.</p>","PeriodicalId":12018,"journal":{"name":"European Journal of Pharmaceutical Sciences","volume":" ","pages":"107720"},"PeriodicalIF":5.1,"publicationDate":"2026-11-14","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149403544","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Obesity-Induced Alterations in Linezolid Tissue Distribution Revealed by Dynamic Positron Emission Tomography Imaging. 动态正电子发射断层成像显示肥胖引起的利奈唑类组织分布改变。
IF 5.1 3区 医学
European Journal of Pharmaceutical Sciences Pub Date : 2026-11-14 DOI: 10.1016/j.ejps.2026.107721
Lara García-Varela, María Gómez-Martínez, Mamina Bhol, Claudia Espósito-Zapero, Andrea Fernández, Francisco Cajade-Pascual, Valentina Dorta, Rubén Nogueiras, Anxo Fernández-Ferreiro, Pablo Aguiar, Jordi Llop, Cristina Mondelo-García
{"title":"Obesity-Induced Alterations in Linezolid Tissue Distribution Revealed by Dynamic Positron Emission Tomography Imaging.","authors":"Lara García-Varela, María Gómez-Martínez, Mamina Bhol, Claudia Espósito-Zapero, Andrea Fernández, Francisco Cajade-Pascual, Valentina Dorta, Rubén Nogueiras, Anxo Fernández-Ferreiro, Pablo Aguiar, Jordi Llop, Cristina Mondelo-García","doi":"10.1016/j.ejps.2026.107721","DOIUrl":"https://doi.org/10.1016/j.ejps.2026.107721","url":null,"abstract":"<p><strong>Background: </strong>The rising prevalence of obesity and its associated susceptibility to infection raise concerns about the adequacy of fixed linezolid dosing. Obesity-related alterations in tissue drug exposure remain poorly characterised. This study quantified the in vivo biodistribution and pharmacokinetics of linezolid in diet-induced obese and control mice using positron emission tomography (PET).</p><p><strong>Methods: </strong>Male C57BL/6J mice received a high-fat (n=6) or standard diet (n=8) for ten weeks. [¹⁸F]F-Linezolid was produced by copper-mediated ¹⁸F-fluorination of a boronic ester precursor under optimised low-base conditions. Following intravenous administration, dynamic whole-body PET images were acquired over 90 minutes, followed by computed tomography (CT) imaging. Volumes of interest (brown and subcutaneous white adipose tissue, heart, knee, brain, and lung) were analysed using radioactivity concentration, total radioactivity, standardised uptake values, and kinetic modelling with an image-derived input function. Plasma radiometabolites were quantified by high-performance liquid chromatography.</p><p><strong>Results: </strong>[¹⁸F]F-Linezolid was obtained with >99% radiochemical purity and molar activity of 28-92 GBq/µmol. Obese mice showed lower blood radioactivity, with comparable parent-fraction profiles between groups. The one-tissue compartment model and Logan analysis provided optimal fits. Volume of distribution was significantly reduced in obese animals exclusively in adipose depots, accompanied by lower influx rate constants, whereas exposure was fully preserved in lung, brain, and bone/joint tissue.</p><p><strong>Conclusion: </strong>Obesity induces selective pharmacokinetic alterations confined to adipose compartments without compromising linezolid delivery to clinically relevant target tissues, revealing a plasma-tissue dissociation and a tissue-specific distribution that may limit the interpretation of plasma-based therapeutic drug monitoring.</p>","PeriodicalId":12018,"journal":{"name":"European Journal of Pharmaceutical Sciences","volume":" ","pages":"107721"},"PeriodicalIF":5.1,"publicationDate":"2026-11-14","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149403547","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Modeling of Eutectic Phase Behavior in Pharmaceutical Mixtures Using the PC-SAFT Equation of State. 用PC-SAFT状态方程模拟药物混合物中共晶相行为。
IF 5.1 3区 医学
European Journal of Pharmaceutical Sciences Pub Date : 2026-11-14 DOI: 10.1016/j.ejps.2026.107716
Sameer Alshehri, Rahamatullah Shaikh, Saeed Shirazian
{"title":"Modeling of Eutectic Phase Behavior in Pharmaceutical Mixtures Using the PC-SAFT Equation of State.","authors":"Sameer Alshehri, Rahamatullah Shaikh, Saeed Shirazian","doi":"10.1016/j.ejps.2026.107716","DOIUrl":"https://doi.org/10.1016/j.ejps.2026.107716","url":null,"abstract":"<p><p>The perturbed-chain statistical associating fluid theory (PC-SAFT) equation of state (EoS) is utilized to estimate eutectic phase behavior in pharmaceutical mixtures. Eutectic formation in pharmaceutical mixtures plays an important role in modifying the melting behavior and solubility of pharmaceuticals. Accurate prediction of eutectic temperature and composition is still challenging due to the presence of strong molecular interactions such as dispersion, chain, repulsion and hydrogen bonding. Drug-drug eutectic systems and drug-deep eutectic solvent (DES) mixtures commonly display V-shaped eutectic phase diagrams. This is due to strong non-ideal interactions in the liquid phase and poor miscibility in the solid state. The SAFT-based models such as the PC-SAFT provides a physically based framework for modeling non-ideal thermodynamic behavior. The molecular interactions between chain-like segments and associating functional groups of drugs and DES molecules were modeled satisfactorily by the PC-SAFT EoS. The pure model parameters have been adjusted using Solid-Liquid Equilibrium (SLE) data at an arbitrary temperature and in various solvents. The obtained parameters have been utilized to predict the eutectic behavior of drug-drug and drug-DES systems. In some cases, a binary interaction coefficient (BIC) was used to improve model performance. PC-SAFT successfully reproduces the eutectic trends observed in pharmaceutical mixtures. The proposed methodology can be used to predict solubility and eutectic phase behavior for drug-drug and drug-DES systems over a wide range of temperatures and molar ratios for newly designed drugs.</p>","PeriodicalId":12018,"journal":{"name":"European Journal of Pharmaceutical Sciences","volume":" ","pages":"107716"},"PeriodicalIF":5.1,"publicationDate":"2026-11-14","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149403546","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Editorial: Current use of 3D printing methods in drug delivery Special Issue. 社论:目前3D打印方法在给药中的应用特刊。
IF 5.1 3区 医学
European Journal of Pharmaceutical Sciences Pub Date : 2026-11-13 DOI: 10.1016/j.ejps.2026.107718
P Arany, E Bilensoy, I Bácskay
{"title":"Editorial: Current use of 3D printing methods in drug delivery Special Issue.","authors":"P Arany, E Bilensoy, I Bácskay","doi":"10.1016/j.ejps.2026.107718","DOIUrl":"https://doi.org/10.1016/j.ejps.2026.107718","url":null,"abstract":"","PeriodicalId":12018,"journal":{"name":"European Journal of Pharmaceutical Sciences","volume":" ","pages":"107718"},"PeriodicalIF":5.1,"publicationDate":"2026-11-13","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149403545","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
CLAY MINERALS AS FUNCTIONAL INGREDIENTS OF CHITOSAN/PVA INKS FOR PRESSURE-ASISTED MICRO-SYRINGE 3D PRINTING OF MEDICAL DEVICES. 粘土矿物作为医用设备压力辅助微注射器3d打印壳聚糖/聚乙烯醇油墨的功能成分。
IF 5.1 3区 医学
European Journal of Pharmaceutical Sciences Pub Date : 2026-11-11 DOI: 10.1016/j.ejps.2026.107714
Fátima García-Villén, Nathaly Valarezo, Laura Zecca, Pilar Cerezo, Anna Imbriano, César Viseras, Raquel Barbosa
{"title":"CLAY MINERALS AS FUNCTIONAL INGREDIENTS OF CHITOSAN/PVA INKS FOR PRESSURE-ASISTED MICRO-SYRINGE 3D PRINTING OF MEDICAL DEVICES.","authors":"Fátima García-Villén, Nathaly Valarezo, Laura Zecca, Pilar Cerezo, Anna Imbriano, César Viseras, Raquel Barbosa","doi":"10.1016/j.ejps.2026.107714","DOIUrl":"https://doi.org/10.1016/j.ejps.2026.107714","url":null,"abstract":"<p><p>Hydrogel-based formulations are promising platforms for chronic wound management since they maintain a moist environment and enable controlled drug delivery. The advancements in 3D printing (3DP) enables the development of medical devices and medicines based on polymers, but their low printability is a limitation to overcome. This study explores chitosan/PVA/clay hydrogels as inks for Pressure-Assisted Micro-syringe 3DP, focusing on the influence of different clay minerals. Chitosan (4% w/w), PVA (2.3% w/w) and triethanolamine (2% w/w) were the basic ingredients, while clays (0.45% w/w laponite, 0.9% w/w montmorillonite, 1.81% w/w sepiolite and halloysite) were added as functional ingredients. The addition of clays made the polymeric mixture printable: Laponite provided the highest printing resolution, sepiolite reported great reproducibility after post-printing and montmorillonite prevented filament collapsing most effectively. FTIR and XRD confirmed interactions among components, such as polymer/clay intercalation, which could explain the printability and compressive Young Modulus improvements. The stability of the printed devices in simulated fluid can be controlled by the type of clay, which can be predicted by the wetting angle of hydrogels. In vitro cytocompatibility studies revealed a cell viability > 90% in all cases, confirming their biocompatibility. This exploratory study demonstrates that clays can modulate the behaviour of polymer mixtures and optimize their 3DP performance, thus enabling the production of personalized and tunable medical devices and/or medicines.</p>","PeriodicalId":12018,"journal":{"name":"European Journal of Pharmaceutical Sciences","volume":" ","pages":"107714"},"PeriodicalIF":5.1,"publicationDate":"2026-11-11","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149393351","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Cyclodextrin-formulated ferrocifen penetrates the brain and significantly improves survival in an orthotopic mouse model of glioblastoma. 环糊精配制的铁西芬穿透大脑,显著提高原位胶质母细胞瘤小鼠模型的存活率。
IF 5.1 3区 医学
European Journal of Pharmaceutical Sciences Pub Date : 2026-11-10 DOI: 10.1016/j.ejps.2026.107715
Anne Vessières, Michèle Salmain, Kawtar Daddi, Pascal Pigeon, Michael J McGlinchey, Julie Noël, Benoît Caron, Regina Maruchenko, Tiffany Andriantsihoarana, Karim Labrèche, Ahmed Idbaih, Maïté Verreault
{"title":"Cyclodextrin-formulated ferrocifen penetrates the brain and significantly improves survival in an orthotopic mouse model of glioblastoma.","authors":"Anne Vessières, Michèle Salmain, Kawtar Daddi, Pascal Pigeon, Michael J McGlinchey, Julie Noël, Benoît Caron, Regina Maruchenko, Tiffany Andriantsihoarana, Karim Labrèche, Ahmed Idbaih, Maïté Verreault","doi":"10.1016/j.ejps.2026.107715","DOIUrl":"https://doi.org/10.1016/j.ejps.2026.107715","url":null,"abstract":"<p><strong>Objectives: </strong>Despite intensive chemotherapeutic and radiotherapeutic approaches for its treatment, glioblastoma (GBM) remains incurable, in part due to the difficulty of active molecules in crossing the blood-brain-barrier (BBB). Developing a suitable formulation for molecules with promising in vitro anticancer activity thus represents an essential step toward their in vivo translation.</p><p><strong>Methods: </strong>We report here the formulation of the lipophilic compound P15, a ferrocenyl analog of hydroxytamoxifen with broad antiproliferative activity, in randomly methylated β-cyclodextrin (RAMEB), together with the extensive characterization of the inclusion complex, pharmacokinetic (PK) studies, and an in vivo efficacy study in an orthotopic model of human glioblastoma in mice.</p><p><strong>Results: </strong>Inclusion of P15 as its citrate salt is significantly more efficient, with a 5 mM solution of RAMEB being able to solubilize 12 times more P15-cit than P15. The inclusion complex P15-cit@RAMEB exhibits a favorable stability constant on the order of 10<sup>4</sup> M<sup>-1</sup>, as determined from the phase solubility diagram. The inclusion complex is characterized by a 2:1 host:guest ratio, with that the ferrocenyl moiety inserted into one of the cyclodextrins while the other incorporates an aromatic ring. PK analyses suggest a marked biodistribution of P15 in the mouse brain following IV administration of P15-cit@RAMEB at 20 mg/kg. Crucially, the survival of orthotopic GBM-bearing mice is significantly improved, resulting in 17-33% long-term survivors. RNA sequencing analysis of treated mouse brains compared with controls reveals that the treatment is associated with the inhibition of pathways related to angiogenesis, metal ion homeostasis and calcium signaling.</p><p><strong>Conclusions: </strong>Formulation of the citrate form of P15 in RAMEB represents a promising strategy for developing a more effective therapy for GBM patients.</p>","PeriodicalId":12018,"journal":{"name":"European Journal of Pharmaceutical Sciences","volume":" ","pages":"107715"},"PeriodicalIF":5.1,"publicationDate":"2026-11-10","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149385956","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Automated Extrusion-based Dispensing of Mucoadhesive Oral Films Containing Buprenorphine for Feline Delivery to the Gingiva. 基于自动挤出的含有丁丙诺啡的粘接口腔薄膜给药方法。
IF 5.1 3区 医学
European Journal of Pharmaceutical Sciences Pub Date : 2026-11-09 DOI: 10.1016/j.ejps.2026.107713
T Lashkari, D Ventoruzzo, E A Winter, W J M van den Bogaard, M P Joustra, R J Kok, S J Mesu, I M van Geijlswijk, J H J Quodbach
{"title":"Automated Extrusion-based Dispensing of Mucoadhesive Oral Films Containing Buprenorphine for Feline Delivery to the Gingiva.","authors":"T Lashkari, D Ventoruzzo, E A Winter, W J M van den Bogaard, M P Joustra, R J Kok, S J Mesu, I M van Geijlswijk, J H J Quodbach","doi":"10.1016/j.ejps.2026.107713","DOIUrl":"https://doi.org/10.1016/j.ejps.2026.107713","url":null,"abstract":"<p><p>Cats are undertreated patients due to their lack of communication, with limited options for oral pain management, and may benefit from individualized oral dosage forms to facilitate at-home pain management. Buprenorphine would be a suitable treatment option with a proven safety profile. It is readily absorbed across the oral mucosa and acts, therefore, systemically. Extemporaneous formulations can be administered buccally to enable at-home treatment of pain, yet the poor palatability of formulations and highly variable absorption limit therapeutic effectiveness and regular clinical translation. However, preparing appropriately sized dosage forms for buprenorphine administration remains challenging. This study evaluated automated extrusion-based dispensing (AED), a simplified extrusion-based 3D printing, as an approach for preparing personalized mucoadhesive oral films (MFs) containing buprenorphine hydrochloride for gingival application in feline analgesia. A formulation consisting of CMC-Na, PEG 400, and water was identified as suitable for AED. The resulting films showed reproducible mass, uniform drug content, suitable pH, and rapid disintegration and drug release. In a preliminary administration trial with 39 cats, placebo MFs were retained at the gingival mucosa and were well accepted, supporting the feasibility of gingival application. Overall, AED enabled the preparation of personalized MFs for feline gingival administration, providing a basis for further development and evaluation of this dosage form.</p>","PeriodicalId":12018,"journal":{"name":"European Journal of Pharmaceutical Sciences","volume":" ","pages":"107713"},"PeriodicalIF":5.1,"publicationDate":"2026-11-09","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149378095","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Nano-in-Gel platforms for the topical treatment of Staphylococcus aureus skin infections. 局部治疗金黄色葡萄球菌皮肤感染的纳米凝胶平台。
IF 5.1 3区 医学
European Journal of Pharmaceutical Sciences Pub Date : 2026-11-08 DOI: 10.1016/j.ejps.2026.107712
Helena Rouco, Irene Vieitez, Carolina Menéndez-Rodríguez, Carmen Potel, Ana Otero, Patricia Diaz-Rodriguez, Mariana Landin
{"title":"Nano-in-Gel platforms for the topical treatment of Staphylococcus aureus skin infections.","authors":"Helena Rouco, Irene Vieitez, Carolina Menéndez-Rodríguez, Carmen Potel, Ana Otero, Patricia Diaz-Rodriguez, Mariana Landin","doi":"10.1016/j.ejps.2026.107712","DOIUrl":"10.1016/j.ejps.2026.107712","url":null,"abstract":"<p><p>Staphylococcus aureus (S. aureus) is the leading cause of skin infections worldwide. Rising antimicrobial resistance limits the effectiveness of current treatments, highlighting the need for new therapeutic strategies. In this context, Rifabutin (RFB), could be repurposed for skin infections based on its strong anti-staphylococcal activity. However, its low oral bioavailability, and the rapid capacity of bacteria to develop drug tolerance, makes necessary to find novel platforms to ensure antimicrobial efficacy. This work proposes the development of Nano-in-Gel drug delivery systems, integrating RFB-loaded nanostructured lipid carriers (NLCs) into gelatin hydrogels for topical administration. These composite materials combine the controlled release capacity of hydrogels with NLCs' ability to maximize RFB clinical potential. RFB-loaded NLCs were prepared and characterized in terms of physicochemical properties and cytocompatibility in human dermal fibroblasts (HDF). Moreover, their antibacterial activity against two different S. aureus strains-including mutants generated after RFB exposure was evaluated using a combination of conventional quantification methods and droplet digital PCR (ddPCR). Following the incorporation of NLCs into the gels, the mechanical properties of the Nano-in-Gel systems, and their ability to modulate nanoparticle release were assessed. Results demonstrated that the RFB-loaded NLCs possessed optimal physicochemical characteristics and high biocompatibility. Furthermore, the nanocarriers exhibited enhanced anti-staphylococcal activity compared to the free drug and successfully overcame RFB-resistance in mutant strains. The Nano-in-Gel platforms showed excellent mechanical performance for topical application and achieved a controlled NLCs release profile. These findings suggest that the Nano-in-Gel systems constitute a promising strategy for the advanced management of S. aureus skin infections.</p>","PeriodicalId":12018,"journal":{"name":"European Journal of Pharmaceutical Sciences","volume":" ","pages":"107712"},"PeriodicalIF":5.1,"publicationDate":"2026-11-08","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"149378094","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
相关产品
×
本文献相关产品
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信
小红书